Amit Hazan
Stock Analyst at Goldman Sachs
(2.11)
# 2,963
Out of 5,241 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $42.53 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $10.66 | -76.55% | 5 | Nov 30, 2022 | |
| SKIN SkinHealth Systems | Maintains: Buy | $22 → $19 | $0.6625 | +2,767.92% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $15.23 | -47.47% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $72.92 | -13.60% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $146.95 | +85.10% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $16.20 | +4.94% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $3.86 | +11,169.43% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $25.91 | +69.82% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $82.16 | -11.15% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $18.33 | +189.14% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $25.76 | +121.27% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $8.22 | +15.57% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $88.82 | +17.09% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $22.29 | +169.18% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $78.58 | +46.35% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $317.75 | -52.79% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $56.81 | -19.03% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $441.58 | -45.27% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $86.08 | +105.62% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $230.00 | -36.09% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $0.2858 | +1,264.59% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $42.53
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $10.66
Upside: -76.55%
SkinHealth Systems
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $0.6625
Upside: +2,767.92%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $15.23
Upside: -47.47%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $72.92
Upside: -13.60%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $146.95
Upside: +85.10%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $16.20
Upside: +4.94%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $3.86
Upside: +11,169.43%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $25.91
Upside: +69.82%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $82.16
Upside: -11.15%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $18.33
Upside: +189.14%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $25.76
Upside: +121.27%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $8.22
Upside: +15.57%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $88.82
Upside: +17.09%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $22.29
Upside: +169.18%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $78.58
Upside: +46.35%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $317.75
Upside: -52.79%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $56.81
Upside: -19.03%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $441.58
Upside: -45.27%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $86.08
Upside: +105.62%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $230.00
Upside: -36.09%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $0.2858
Upside: +1,264.59%